<DOC>
	<DOCNO>NCT00658554</DOCNO>
	<brief_summary>This bioequivalence study design compare three solid state ARQ 197 normal healthy volunteer use randomize crossover design .</brief_summary>
	<brief_title>Bioequivalence Study ARQ 197 Amorphous Crystalline Polymorphs A B Normal Healthy Volunteers</brief_title>
	<detailed_description>This bioequivalence study design compare three solid state ARQ 197 normal healthy volunteer use randomize crossover design . The primary objective obtain pharmacokinetic data assess bioequivalence among three solid state ARQ 197 : amorphous , crystalline polymorph A crystalline polymorph B .</detailed_description>
	<criteria>Subject must provide write informed consent prior study related procedure Subjects must age 18 65 year Male participant must surgically sterilize Female participant must surgically sterilize post menopausal must negative serum pregnancy test All participant phenotypically extensive metabolizers base CYP C19 genotype . Males surgically sterilize Females childbearing potential surgically sterilize Any clinically significant acute unstable physical psychological disease base medical history screen physical examination Any clinically significant abnormality screen laboratory test ECG Received investigational drug within four week Human immunodeficiency virus ( HIV ) , hepatitis B virus ( HBV ) hepatitis C virus ( HCV ) infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2008</verification_date>
</DOC>